Sort
50,496 grants matching “lung cancer”
Integrated, Individualized, Intelligent Prescribing (I3P)
$1,027,757Joshua C. Denny · Vanderbilt University Medical Center · U01 · FY2016 · HG
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2018 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2017 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2016 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,027,469Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
A Handheld Microchip for GC analysis of breath to screen for COVID-19
$1,026,672Xiao-An Fu · University Of Louisville · U18 · FY2021 · TR
Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance
$1,026,576Pasi A Janne · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance
$1,026,576Pasi A Janne · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Development of Medical Multiphoton Microscopic Endoscopy
$1,026,539Watt W Webb · Cornell University · R01 · FY2011 · EB
Clinical production of viral vectors for cancer gene therapy
$1,026,237Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
A genomewide study of lung cancer in never smokers
$1,025,637Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
How do genome alterations cause human lung cancer?
$1,025,600Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2015 · CA
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$1,025,393Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2016 · CA
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
$1,025,217Catherine M. Tangen · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,025,166Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$1,024,973Yen Tun Wang · Curebiotech, Inc. · R44 · FY2019 · CA
DNA Replication, Cancer and Chemotherapy
$1,024,926Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$1,024,684Robert A Salata · Case Western Reserve University · U54 · FY2020 · CA
Etiological Studies of Gastric Carcinoma
$1,024,383Pelayo Correa · Vanderbilt University · P01 · FY2012 · CA
The MYC Transcription Factor Network and the Path to Cancer
$1,024,317Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2019 · CA
Single-molecule measurements of DNA topology and topoisomerases
$1,024,272Keir Neuman · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
SUPPORT SERVICES FOR THE PLCO ETIOLOGIC&EARLY MARKER STUDIES (PLCO EEMS)
$1,024,263Thomas Riley · Information Management Services, Inc. · N02 · FY2021 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,023,737Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Biospecimen procurement and tissue microarray manufacture for the CHTN
$1,023,730Christopher A. Moskaluk · University Of Virginia · UM1 · FY2019 · CA